An AI method to predict pregnancy loss by extracting biological indicators from embryo ultrasound recordings in early pregnancy.

Journal: Scientific reports
Published Date:

Abstract

B-ultrasound results are widely used in early pregnancy loss (EPL) prediction, but there are inevitable intra-observer and inter-observer errors in B-ultrasound results especially in early pregnancy, which lead to inconsistent assessment of embryonic status, and thus affect the judgment of EPL. To address this, we need a rapid and accurate model to predict pregnancy loss in the first trimester. This study aimed to construct an artificial intelligence model to automatically extract biometric parameters from ultrasound videos of early embryos and predict pregnancy loss. This can effectively eliminate the measurement error of B-ultrasound results, accurately predict EPL, and provide decision support for doctors with relatively little clinical experience. A total of 630 ultrasound videos from women with early singleton pregnancies of gestational age between 6 and 10 weeks were used for training. A two-stage artificial intelligence model was established. First, some biometric parameters such as gestational sac areas (GSA), yolk sac diameter (YSD), crown rump length (CRL) and fetal heart rate (FHR), were extract from ultrasound videos by a deep neural network named A3F-net, which is a modified neural network based on U-Net designed by ourselves. Then an ensemble learning model predicted pregnancy loss risk based on these features. Dice, IOU and Precision were used to evaluate the measurement results, and sensitivity, AUC etc. were used to evaluate the predict results. The fetal heart rate was compared with those measured by doctors, and the accuracy of results was compared with other AI models. In the biometric features measurement stage, the precision of GSA, YSD and CRL of A3F-net were 98.64%, 96.94% and 92.83%, it was the highest compared to other 2 models. Bland-Altman analysis did not show systematic deviations between doctors and AI. The mean and standard deviation of the mean relative error between doctors and the AI model was 0.060 ± 0.057. In the EPL prediction stage, the ensemble learning models demonstrated excellent performance, with CatBoost being the best-performing model, achieving a precision of 98.0% and an AUC of 0.969 (95% CI: 0.962-0.975). In this study, a hybrid AI model to predict EPL was established. First, a deep neural network automatically measured the biometric parameters from ultrasound video to ensure the consistency and accuracy of the measurements, then a machine learning model predicted EPL risk to support doctors making decisions. The use of our established AI model in EPL prediction has the potential to assist physicians in making more accurate and timely clinical decision in clinical application.

Authors

  • Lijue Liu
    School of Automation, Central South University, Changsha, Hunan, 410083, China. ljliu@csu.edu.cn.
  • Yuan Zang
    School of Automation, Central South University, Changsha, 410083, Hunan, China.
  • Huimu Zheng
    Longgang District Maternity & Child Healthcare Hospital of Shenzhen City (Longgang Maternity and Child Institute of Shantou University Medical College), Shenzhen, 518172, China.
  • Siya Li
    CAS Blue Bay Cloud Technology (Guangdong) Co., Ltd., Guangzhou, 518001, China.
  • Yu Song
    Department of Systems Management, Fukuoka Institute of Technology, Fukuoka, Japan.
  • Xue Feng
    Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, Virginia.
  • Xiyuan Zhang
    Department of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Changsha City, China.
  • Yaoxu Li
    Clinical Research Center (CRC), Medical Pathology Center (MPC), Cancer Early Diagnosis and Treatment Center (CEDTC) and Translational Medicine Research Center (TMRC), School of Medicine, Chongqing University Three Gorges Hospital, Chongqing University, Wanzhou District, Chongqing, 404100, China.
  • Lulu Cao
    Department of Rheumatology and Immunology, Peking University People's Hospital, 100044, China.
  • Guanglin Zhou
    College of New Energy and Materials, China University of Petroleum-Beijing Beijing 102249 China zhouguanglin2@163.com.
  • Tingting Dong
    Anhui Provincial Key Laboratory of Molecular Enzymology and Mechanism of Major Metabolic Diseases, Anhui Provincial Engineering Research Centre for Molecular Detection and Diagnostics, College of Life Sciences, Anhui Normal University, Wuhu, China.
  • Qi Huang
    State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural Universitygrid.35155.37, Wuhan, China.
  • Teng Pan
    Longgang District Maternity & Child Healthcare Hospital of Shenzhen City, Longgang Maternity and Child Institute of Shantou University Medical College, Shenzhen, 518172, China.
  • Jinhai Deng
    Clinical Research Center (CRC), Medical Pathology Center (MPC), Cancer Early Diagnosis and Treatment Center (CEDTC) and Translational Medicine Research Center (TMRC), Chongqing University Three Gorges Hospital, School of Medicine, Chongqing, 404100, China. jinhaideng_kcl@163.com.
  • Danling Cheng
    The Genetics Laboratory, Longgang District Maternity and Child Healthcare Hospital of Shenzhen City (Longgang Maternity and Child Institute of Shantou University Medical College), Shenzhen, Longgang District, Guangdong Province, 518712, China.